Pakistan eyes joint vaccine, pharma production with China amid looming funding crunch
- Health minister says Pakistan imports 80–90 percent of pharmaceutical raw materials
- Officials warn vaccine costs could rise to $1.2 billion annually after donor support ends by 2030
